BRCA1 participates in DNA decatenation

Nature Structural and Molecular Biology

Volumn 12, Issue 7, 2005, Pages 589-593

  Lou, Zhenkun ^a   Minter Dykhouse, Katherine ^a   Chen, Junjie ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 BIS(3,5 DIOXO 1 PIPERAZINYL)BUTANE; BRCA1 PROTEIN; DNA; DNA TOPOISOMERASE (ATP HYDROLYSING) A; GYRASE INHIBITOR; NOCODAZOLE; SMALL INTERFERING RNA; TUMOR SUPPRESSOR PROTEIN;

AGAR GEL ELECTROPHORESIS; ARTICLE; CELL CYCLE; CELL CYCLE S PHASE; CELL STRAIN; CELL STRAIN HCC1937; CHROMOSOME CONDENSATION; CHROMOSOME SEGREGATION; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; GENOMIC IN SITU HYBRIDIZATION; HELA CELL; HOMOLOGOUS RECOMBINATION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; UBIQUITINATION;

ANTIGENS, NEOPLASM; BRCA1 PROTEIN; CELLS, CULTURED; CHROMOSOME SEGREGATION; CYTOGENETIC ANALYSIS; DNA; DNA TOPOISOMERASES, TYPE II, EUKARYOTIC; DNA-BINDING PROTEINS; FLUORESCENT ANTIBODY TECHNIQUE; GENOMIC INSTABILITY; IMMUNOBLOTTING; IMMUNOPRECIPITATION; RNA, SMALL INTERFERING; S PHASE; TRANSFECTION; UBIQUITIN;

EID: 22144450678     PISSN: 15459993     EISSN: None     Source Type: Journal    
DOI: 10.1038/nsmb953     Document Type: Article

References (34)

1. Venkitaraman, A.R. Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell 108, 171-182 (2002).
2. Scully, R. & Livingston, D.M. In search of the tumour-suppressor functions of BRCA1 and BRCA2. Nature 408, 429-432 (2000).
3. Kerr, P. & Ashworth, A. New complexities for BRCA1 and BRCA2. Curr. Biol. 11, R668-R676 (2001).
4. Brodie, S.G. & Deng, C.X. BRCA1-associated tumorigenesis: what have we learned from knockout mice? Trends Genet. 17, S18-S22 (2001).
5. Xu, X. et al. Genetic interactions between tumor suppressors Brca1 and p53 in apoptosis, cell cycle and tumorigenesis. Nat. Genet. 28, 266-271 (2001).
6. Xu, X. et al. Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation. Nat. Genet. 22, 37-43 (1999).
7. Scully, R. et al. Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage. Cell 90, 425-435 (1997).
8. Scully R. et al. Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cell 88, 265-275 (1997).
9. Agostinho, M. et al. Human topoisomerase IIalpha: targeting to subchromosomal sites of activity during interphase and mitosis. Mol. Biol. Cell 15, 2388-2400 (2004).
10. Niimi, A., Suka, N., Harata, M., Kikuchi, A. & Mizuno, S. Co-localization of chicken DNA topoisomerase IIalpha, but not beta, with sites of DNA replication and possible involvement of a C-terminal region of alpha through its binding to PCNA. Chromosome 110, 102-114 (2001).
11. Yu, X., Chini, C.C., He, M., Mer, G. & Chen, J. The BRCT domain is a phospho-protein binding domain. Science 301, 639-642 (2003).
12. Manke, I.A., Lowery, D.M., Nguyen, A. & Yaffe, M.B. BRCT repeats as phosphopeptide-binding modules involved in protein targeting. Science 302, 636-639 (2003).
13. Wang, J.C. DNA topoisomerases. Annu. Rev. Biochem. 65, 635-692 (1996).
14. Ishida, R. et al. Inhibition of intracellular topoisomerase II by antitumor bis(2,6-dioxopiperazine) derivatives: mode of cell growth inhibition distinct from that of cleavable complex-forming type inhibitors. Cancer Res. 51, 4909-4916 (1991).
15. Clarke, D.J., Johnson, R.T. & Downes, C.S. Topoisomerase II inhibition prevents anaphase chromatid segregation in mammalian cells independently of the generation of DNA strand breaks. J. Cell Sci. 105, 563-569 (1993).
16. Yarden, R.I., Pardo-Reoyo, S., Sgagias, M., Cowan, K.H. & Brody, L.C. BRCA1l regulates the G2/M checkpoint by activating Chk1 kinase upon DNA damage. Nat. Genet. 30, 285-289 (2002).
17. Lucas, I., Germe, T., Chevrier-Miller, M. & Hyrien, O. Topoisomerase II can unlink replicating DNA by precatenane removal. EMBO J. 20, 6509-6519 (2001).
18. Marini, J.C. Miller, K.G. & Englund, P.T. Decatenation of kinetoplast DNA by topoisomerases. J. Biol. Chem. 255, 4976-4979 (1980).
19. Poljak, L. & Kas, E. Resolving the role of topoisomerase II in chromatin structure and function. Trends Cell Biol. 5, 348-354 (1995).
20. Taagepera, S., Rao, P.N., Drake, F.H. & Gorbsky, G.J. DNA topoisomerase IIl alpha is the major chromosome protein recognized by the mitotic phosphoprotein antibody MPM-2. Proc. Natl Acad. Sci. USA 90, 8407-8411 (1993).
21. Baer, R. & Ludwig, T. The BRCA1/BARD1 heterodimer, a tumor suppressor complex with ubiquitin E3 ligase activity. Curr. Opin. Genet. Dev. 12, 86-91 (2002).
22. Starita, L.M. & Parvin, J.D. The multiple nuclear functions of BRCA1: transcription, ubiquitination and DNA repair. Curr. Opin. Cell Biol. 15, 345-350 (2003).
23. Salmena, L., Lam, V., McPherson, J.P & Goldenberg, G.J. Role of proteasomal degradation in the cell cycle-dependent regulation of DNA topoisomerase IIalpha expression. Biochem. Pharmacol. 61, 795-802 (2001).
24. Bachant, J., Alcasabas, A., Blat, Y., Kleckner, N. & Elledge, S.J. The SUMO-1 isopeptidase Smt4 is linked to centromeric cohesion through SUMO-1 modification of DNA topoisomerase II. Mol. Cell 9, 1169-1182 (2002).
25. Azuma, Y., Arnaoutov, A. & Dasso, M. SUMO-2/3 regulates topoisomerase II in mitosis. J. Cell Biol. 163, 477-487 (2003).
26. Meyer, K.N. et al. Cell cycle-coupled relocation of types I and II topoisomerases and modulation of catalytic enzyme activities. J. Cell Biol. 136, 775-788 (1997).
27. Wang, R.H., Yu, H. & Deng, C.X. A requirement for breast-cancer-associated gene 1 (BRCA1) in the spindle checkpoint. Proc. Natl Acad. Sci. USA 101, 17108-17113 (2004).
28. Gimenez-Abian, J.F. et al. Premitotic chromosome individualization in mammalian cells depends on topoisomerase II activity. Chromosoms 109, 235-244 (2000).
29. Deming, P.B. et al. The human decatenation checkpoint. Proc. Natl Acad. Sci. USA 98, 12044-12049 (2001).
30. Scully, R. et al. Location of BRCA1 in human breast and ovarian cancer cells. Science 212, 123-126 (1996).
31. Chen, J.J., Silver, D., Cantor, S., Livingston, D.M. & Scully, R. BRCA1, BRCA2, and Rad51 operate in a common DNA damage response pathway. Cancer Res. 59, 1752s-1756s (1999).
32. Rappold, I., Iwabuchi, K., Date, T. & Chen, J. Tumor suppressor p53 binding protein 1 (53BP1) is involved in DNA damage-signaling pathways. J. Cell Biol. 153, 613-620 (2001).
33. Lou, Z., Minter-Dykhouse, K., Wu, X. & Chen, J, MDC1 is coupled to activated CHK2 in mammalian DNA damage response pathways. Nature 421, 957-961 (2003).
34. Lou, Z., Chini, C.C., Minter-Dykhouse, K. & Chen, J. Mediator of DNA damage checkpoint protein 1 regulates BRCA1 localization and phosphorylation in DNA damage checkpoint control. J. Biol. Chem. 278, 13599-13602 (2003).